This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: University of Illinois. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Arun Maji: Innovator in Pharmaceutical Chemistry
Introduction
Arun Maji is a notable inventor based in Champaign, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on hybrid amide derivatives of amphotericin B. His research focuses on improving clinical efficacy while reducing toxicity, which is crucial in the development of effective treatments.
Latest Patents
Arun Maji holds a patent for hybrid amide derivatives of amphotericin B. This patent discloses C16 amide derivatives of C2'-epi-amphotericin B (C2′epiAmB) and salts thereof. These compounds are characterized by their improved clinical efficacy and reduced toxicity compared to traditional amphotericin B (AmB). The patent also includes pharmaceutical compositions that comprise these compounds or their salts, along with methods of treatment and therapeutic uses.
Career Highlights
Arun Maji is affiliated with the University of Illinois, where he continues to advance his research in pharmaceutical chemistry. His work has garnered attention for its potential to enhance treatment options for various medical conditions.
Collaborations
Arun Maji collaborates with Martin D Burke, a fellow researcher, to further explore the applications of his patented compounds. Their partnership exemplifies the collaborative spirit in academic research, aiming to push the boundaries of pharmaceutical innovation.
Conclusion
Arun Maji's contributions to the field of pharmaceutical chemistry, particularly through his patent on hybrid amide derivatives of amphotericin B, highlight his commitment to improving clinical outcomes. His work at the University of Illinois and collaborations with other researchers underscore the importance of innovation in medicine.